Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and…

Pelago Bioscience acquires RG Discovery, integrating cellular target engagement (CETSA®) with medicinal chemistry to cover the full DMTA cycle. Vertical consolidation in pharma CROs: fewer vendor handoffs, single-source negotiation, and reduced inter-functional coordination overhead for biotech teams.